生物资讯市场规模、份额及成长分析（按产品、应用、细分市场和地区）－2025-2032 年产业预测

预计 2023 年全球生物资讯市场规模将达到 116 亿美元，并从 2024 年的 131.7 亿美元成长到 2032 年的 362.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 13.5%。

预计生物资讯市场在预测期内将出现显着增长，这主要归因于私人和公共对医药研发的投资增加。 RasMol、AUTODOCK 和 Bioclipse 等用户友好的生物资讯学软体增强了数据可访问性和分析能力，使其成为研发倡议的必需品。随着各个「组学」领域的研究项目不断扩展，对复杂资料储存和分析解决方案的需求可能会增加。值得注意的是，DNA序列测定技术的进步，例如史丹佛大学医学院报告的技术，使得在大约八小时内解码人类基因组成为可能，进一步增加了对基因组分析的需求。这一激增凸显了生物资讯学在解决与遗传疾病、化学预防和致癌性研究相关的复杂挑战中的重要性，并强调了该领域在现代医学中发挥的关键作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 监管分析
• 技术分析
• 案例研究

生物资讯市场规模（依产品/服务）

• 市场概览
• 知识管理工具
  • 通用知识管理工具
  • 专业的知识管理工具
• 生物资讯平台
  • 数据分析平台
  • 结构与功能分析平台
  • 其他生物资讯平台
• 生物资讯服务
  • 定序服务
  • 数据分析服务
  • 药物研发服务
  • 差异基因表现分析服务
  • 资料库和管理服务
  • 其他生物资讯服务

生物资讯市场规模（按应用）

• 市场概览
• 基因组学
• 化学资讯学与药物设计
• 蛋白质体学
• 转录组学
• 代谢体学
• 其他用途

生物资讯市场规模（按领域）

• 市场概览
• 医学生物技术
  • 药物研发
  • 临床诊断与个人化医疗
  • 生殖健康
• 动物生物技术
• 植物生物技术
• 环境生物技术
• 法医学生物技术
• 其他行业

生物资讯市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Illumina Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• Qiagen NV（Netherlands）
• Agilent Technologies Inc.（US）
• BGI Group（China）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Europe）
• Waters Corporation（US）
• DNAnexus Inc.（US）
• Sophia Genetics SA（Switzerland）
• Partek Incorporated（US）
• Gene Codes Corporation（US）
• Dassault Systemes SE（France）
• Biomax Informatics AG（Germany）
• Bruker Corporation（US）
• Macrogen Inc.（South Korea）

结论和建议

Global Bioinformatics Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 13.17 billion in 2024 to USD 36.26 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The bioinformatics market is poised for significant growth during the forecast period, primarily driven by escalating private and public investments in drug research and development. User-friendly bioinformatics software such as RasMol, AUTODOCK, and Bioclipse enhance data accessibility and analysis, making them integral to R&D initiatives. As research programs expand across various '-omics' fields, the demand for sophisticated data storage and analytical solutions is set to increase. Notably, advancements in DNA sequencing technologies, like those reported by Stanford Medicine, can now decode the human genome in about eight hours, further propelling the demand for genomic analysis. This surge emphasizes the importance of bioinformatics in addressing complex challenges related to genetic diseases, chemoprevention, and carcinogen research, underscoring the sector's critical role in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segments Analysis

Global Bioinformatics Market is segmented by Product, Application, Sector and region. Based on Product, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics and Other Applications. Based on Sector, the market is segmented into Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Other Sectors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioinformatics Market

The expansion of personalized medicine is a significant catalyst for the global bioinformatics market. As healthcare shifts toward tailored treatment approaches grounded in individual genetic profiles, there is a rising necessity for bioinformatics tools designed to process and analyze extensive genetic datasets. This escalating demand is propelling the utilization of bioinformatics across pharmaceutical sectors, enhancing diagnostics, evaluation processes, and treatment alternatives. Consequently, the integration of advanced bioinformatics solutions is becoming essential to leverage genetic insights effectively, ultimately fostering more precise and personalized healthcare outcomes. This trend highlights the pivotal role bioinformatics plays in the future of medicine.

Restraints in the Global Bioinformatics Market

The Global Bioinformatics market faces significant challenges due to the high expenses linked to software, hardware, and services. The substantial investment required for bioinformatics systems can pose a financial burden, particularly for smaller research institutions and companies, especially in developing regions with limited market expansion potential. These costs can act as a barrier to entry, inhibiting the adoption of innovative bioinformatics solutions and restricting the overall growth of the market. Consequently, organizations may struggle to access the necessary tools and technologies that facilitate advancements in research and development within the biosciences sector.

Market Trends of the Global Bioinformatics Market

The Global Bioinformatics market is increasingly driven by the integration of artificial intelligence (AI) and machine learning (ML), positioning these technologies as vital components of bioinformatics solutions. These AI-powered tools enhance data analysis capabilities, allowing for expedited and precise interpretation of complex biological datasets. The trend signifies a shift towards improved predictive modeling, more refined pattern recognition, and sophisticated decision-making strategies across various applications, including drug discovery, genomics, and personalized medicine. As the demand for faster and more reliable insights into biological phenomena grows, the bioinformatics sector is poised for robust growth, fostering innovation and collaboration within the life sciences industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Bioinformatics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
• Bioinformatics Platforms
  • Data Analysis Platforms
  • Structural & Functional Analysis Platforms
  • Other Bioinformatics Platforms
• Bioinformatics Services
  • Sequencing Services
  • Data Analysis Services
  • Drug Discovery Services
  • Differential Gene Expression Analysis Services
  • Database And Management Services
  • Other Bioinformatics Services

Global Bioinformatics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Genomics
• Chemoinformatics & Drug Design
• Proteomics
• Transcriptomics
• Metabolomics
• Other Applications

Global Bioinformatics Market Size by Sector & CAGR (2025-2032)

• Market Overview
• Medical Biotechnology
  • Drug Discovery & Development
  • Clinical Diagnostics & Personalized Medicine
  • Reproductive Health
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Other Sectors

Global Bioinformatics Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, Sector)
  • US
  • Canada
• Europe (Product & Service, Application, Sector)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, Sector)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, Sector)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, Sector)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Europe)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAnexus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sophia Genetics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene Codes Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomax Informatics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations